Learn More About The 2026 Summit
This January, join 80+ ocular experts to explore long-acting intravitreal and subretinal innovations, emerging suprachoroidal techniques, novel formulation strategies, drug-device integration, and evolving regulatory expectations at the 4th Ophthalmic Drug Delivery Summit.
Learn more about why you should connect with trailblazers from firms like Genentech, Re-Vana Therapeutics, Adverum, Regeneron, and more - leaders redefining how novel technologies are shaping ocular drug delivery.
Explore the Full Event Guide
- 3 days of cutting-edge ophthalmic drug delivery content
- 3 interactive pre-conference workshops
- Long-acting, gene & cell therapy, topical, implantable & suprachoroidal delivery
- Insights from leaders at Eli Lilly, Genentech, Sanofi, Astellas & more
- Speed networking, roundtables, panels and poster sessions designed for meaningful industry connection
Explore The Latest Delivery Innovations
See how long acting, suprachoroidal, implantable and topical technologies are changing the possibilities for ocular therapy to identify approaches that could improve durability, efficacy and patient outcomes.
Meet Experts Shaping the Field
Connect with the scientists, clinicians, developers and technology leaders solving the industry's toughest delivery challenges to build relationships that can accelerate your next program.
Move Your Program Forward
Take practical insights from toxicology and translation through to regulatory, manufacturing and clinical development, helping you de-risk development and accelerate your path to the clinic .